Cellular Biomedicine Group

136 articles about Cellular Biomedicine Group

• CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution

  1/19/2018

  There are more than 900 regenerative medicine trials underway globally, including trials in cell and gene therapy, a 19 percent increase since 2016

• Cellular Biomedicine Raises $14.5M for CAR-T Immunotherapy, Stem Cells

  12/29/2017

  Cellular Biomedicine added $14.5M into its treasury through two private placements, one to key executives and the other to outside investors.

• Cellular Biomedicine Group Announces Closing of $14.5M Private Placement Offering

  12/28/2017

  The Company intends to use the proceeds from the financings to fund clinical trials and more.

• Cellular Biomedicine Group Reports Third Quarter Financial Results and Recent Operational Highlights

  11/9/2017

  $16.3 million cash and cash equivalents as of September 30, 2017 as compared to $27.3 million as of June 30, 2017.

• Cellular Biomedicine Group Opens its New Shanghai GMP Facility and Joint Laboratory

  11/7/2017

  The company held a Grand Opening ceremony on November 4, 2017 for its new Shanghai facility located in “Pharma Valley” in Shanghai Zhangjiang High-Tech Park.

• Thermo Fisher Scientific and Cellular Biomedicine Group Announce Strategic Partnership to Develop Manufacturing Processes

  11/6/2017

  The partnership focuses on the research and development of an automated cell therapy manufacturing system.

• Cellular Biomedicine Group Plans Grand Opening Of Its New Shanghai Facility

  9/22/2017

• BioLife Solutions, Inc. CryoStor Cell Freeze Media Embedded In Cellular Biomedicine Group Clinical Trial Of AlloJoin

  9/19/2017

• Cellular Biomedicine Group Reports Second Quarter And First Half 2017 Financial Results And Business Highlights

  8/9/2017

• Cellular Biomedicine Group Appoints Dr. Xia Meng As Chief Operating Officer To Lead Commercialization Of The Company’s CAR-T And Stem Cell Products

  6/26/2017

• Cellular Biomedicine Group Appoints Michael A. Caligiuri, MD As Chair Of External Advisory Board

  6/20/2017

• Cellular Biomedicine Group (CBMG) Announces Publication Titled "Target Cell Killing Effects Of CD20 Targeting Chimeric Antigen Receptor T Cells Derived From The Type Ii Anti-CD20 Antibody" In Conjunction With 2017 ASCO Annual Meeting

  5/22/2017

• Cellular Biomedicine Group And GE Healthcare Life Sciences China Announce Strategic Partnership To Establish Joint Technology Laboratory To Develop Control Processes For The Manufacture Of CAR-T And Stem Cell Therapies

  4/10/2017

• Cellular Biomedicine Group Announces Completion Of Wuxi GMP Facility Expansion

  3/30/2017

• Cellular Biomedicine Group Awarded $2.29 Million Grant From The California Institute For Regenerative Medicine (CIRM) To Fund AlloJoin Allogeneic Stem Cell Therapy For Knee Osteoarthritis (KOA) In The U.S.

  2/27/2017

• Cellular Biomedicine Group, A China-US Biopharma, Starts China Trial Of CAR-T Immunotherapy

  12/1/2016

• Cellular Biomedicine Group Lands $43 Million From Wuhan Dangdai

  2/8/2016

• Cellular Biomedicine Group To Present At The Piper Jaffray 27th Annual Healthcare Investor Conference

  11/24/2015

• Cellular Biomedicine Group Opens Beijing Facility

  11/10/2015

• Cellular Biomedicine Group Presented Phase IIa Results From CAR-T CD20 Immuno-Oncology Clinical Development Program for Advanced B-cell Non-Hodgkin Lymphoma

  10/28/2015